Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
83,427 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | Health Net Oregon | Pralsetinib (Gavreto); CP.PHAR.514 | New policy |
| Aug 2, 2026 | Health Net Oregon | Ponatinib (Iclusig); CP.PHAR.112 | New policy |
| Aug 2, 2026 | Health Net Oregon | Pirtobrutinib (Jaypirca); CP.PHAR.620 | New policy |
| Aug 2, 2026 | Health Net Oregon | Pexidartinib (Turalio); CP.PHAR.436 | New policy |
| Aug 2, 2026 | Health Net Oregon | Pemigatinib (Pemazyre); CP.PHAR.496 | New policy |
| Aug 2, 2026 | Health Net Oregon | Pazopanib (Votrient); CP.PHAR.81 | New policy |
| Aug 2, 2026 | Health Net Oregon | Palbociclib (Ibrance); CP.PHAR.125 | New policy |
| Aug 2, 2026 | Health Net Oregon | Pacritinib (Vonjo); CP.PHAR.583 | New policy |
| Aug 2, 2026 | Health Net Oregon | Osimertinib (Tagrisso); CP.PHAR.294 | New policy |
| Aug 2, 2026 | Health Net Oregon | Olutasidenib (Rezlidhia); CP.PHAR.615 | New policy |
| Aug 2, 2026 | Health Net Oregon | Olaparib (Lynparza); CP.PHAR.360 | New policy |
| Aug 2, 2026 | Health Net Oregon | Nirogacestat (Ogsiveo); CP.PHAR.671 | New policy |
| Aug 2, 2026 | Health Net Oregon | Niraparib (Zejula); CP.PHAR.408 | New policy |
| Aug 2, 2026 | Health Net Oregon | Nilotinib (Tasigna, Danziten); CP.PHAR.76 | New policy |
| Aug 2, 2026 | Health Net Oregon | Neratinib (Nerlynx); CP.PHAR.365 | New policy |
| Aug 2, 2026 | Health Net Oregon | Momelotinib (Ojjaara); CP.PHAR.654 | New policy |
| Aug 2, 2026 | Health Net Oregon | Mirdametinib (Gomekli); CP.PHAR.718.pdf | New policy |
| Aug 2, 2026 | Health Net Oregon | Midostaurin (Rydapt); CP.PHAR.344 | New policy |
| Aug 2, 2026 | Health Net Oregon | Lorlatinib (Lorbrena); CP.PHAR.406 | New policy |
| Aug 2, 2026 | Health Net Oregon | Lenvatinib (Lenvima); CP.PHAR.138 | New policy |
| Aug 2, 2026 | Health Net Oregon | Larotrectinib (Vitrakvi); CP.PHAR.414 | New policy |
| Aug 2, 2026 | Health Net Oregon | Lapatinib (Tykerb); CP.PHAR.79 | New policy |
| Aug 2, 2026 | Health Net Oregon | Ixazomib (Ninlaro); CP.PHAR.302 | New policy |
| Aug 2, 2026 | Health Net Oregon | Ivosidenib (Tibsovo); CP.PHAR.137 | New policy |
| Aug 2, 2026 | Health Net Oregon | Inavolisib (Itovebi); CP.PHAR.702 | New policy |
| Aug 2, 2026 | Health Net Oregon | Imatinib (Gleevec, Imkeldi); CP.PHAR.65 | New policy |
| Aug 2, 2026 | Health Net Oregon | Imetelstat (Rytelo); CP.PHAR.690 | New policy |
| Aug 2, 2026 | Health Net Oregon | Idelalisib (Zydelig); CP.PHAR.133 | New policy |
| Aug 2, 2026 | Health Net Oregon | Ibrutinib (Imbruvica); CP.PHAR.126 | New policy |
| Aug 2, 2026 | Health Net Oregon | Gilteritinib (Xospata); CP.PHAR.412 | New policy |
| Aug 2, 2026 | Health Net Oregon | Gefitinib (Iressa); CP.PHAR.68 | New policy |
| Aug 2, 2026 | Health Net Oregon | Futibatinib (Lytgobi); CP.PHAR.604 | New policy |
| Aug 2, 2026 | Health Net Oregon | Fedratinib (Inrebic); CP.PHAR.442 | New policy |
| Aug 2, 2026 | Health Net Oregon | Everolimus (Afinitor, Afinitor Disperz, Zortress); CP.PHAR.63 | New policy |
| Aug 2, 2026 | Health Net Oregon | Erlotinib (Tarceva); CP.PHAR.74 | New policy |
| Aug 2, 2026 | Health Net Oregon | Erdafitinib (Balversa); CP.PHAR.423 | New policy |
| Aug 2, 2026 | Health Net Oregon | Entrectinib (Rozlytrek); CP.PHAR.441 | New policy |
| Aug 2, 2026 | Health Net Oregon | Ensartinib (Ensacove); CP.PHAR.712 | New policy |
| Aug 2, 2026 | Health Net Oregon | Encorafenib (Braftovi); CP.PHAR.127 | New policy |
| Aug 2, 2026 | Health Net Oregon | Enasidenib (Idhifa); CP.PHAR.363 | New policy |
| Aug 2, 2026 | Health Net Oregon | Duvelisib (Copiktra); CP.PHAR.400 | New policy |
| Aug 2, 2026 | Health Net Oregon | Dasatinib (Sprycel, Phyrago); CP.PHAR.72 | New policy |
| Aug 2, 2026 | Health Net Oregon | Dacomitinib (Vizimpro); CP.PHAR.399 | New policy |
| Aug 2, 2026 | Health Net Oregon | Dabrafenib (Tafinlar); CP.PHAR.239 | New policy |
| Aug 2, 2026 | Health Net Oregon | Crizotinib (Xalkori); CP.PHAR.90 | New policy |
| Aug 2, 2026 | Health Net Oregon | Cobimetinib (Cotellic); CP.PHAR.380 | New policy |
| Aug 2, 2026 | Health Net Oregon | Ceritinib (Zykadia); CP.PHAR.349 | New policy |
| Aug 2, 2026 | Health Net Oregon | Carfilzomib (Kyprolis); CP.PHAR.309 | New policy |
| Aug 2, 2026 | Health Net Oregon | Capmatinib (Tabrecta); CP.PHAR.494 | New policy |
| Aug 2, 2026 | Health Net Oregon | Capivasertib (Truqap); CP.PHAR.663 | New policy |